Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial

Affiliations

• ¹ HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, and the University of Geneva Faculty of Medicine, Geneva, Switzerland.
• ² Private Practice Office, Geneva, Switzerland.
• ³ Division of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
• ⁴ Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
• ⁵ Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland.
• ⁶ Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, University of Basel, Basel, Switzerland.
• ⁷ Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
• ⁸ University of Geneva and University of Southern Switzerland, Lugano, Switzerland.
• ⁹ Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
• ¹⁰ Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
• ¹¹ Division of Infectious Diseases and Hospital Epidemiology, Kantonspital St. Gallen, St. Gall, Switzerland.
• ¹² Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
• ¹³ Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
• ¹⁴ CTU Bern, University of Bern, Bern, Switzerland.